Global Drug Subcontractor Market Growth 2026-2032

April 2026 | 119 pages | ID: G8D6F9C7577FEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Drug Subcontractor market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Drug Subcontractor is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Drug Subcontractor is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Drug Subcontractor is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Drug Subcontractor players cover JVM, Takazono Corporation, TOSHO, JHNT, SANYO, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Drug Subcontractor Industry Forecast” looks at past sales and reviews total world Drug Subcontractor sales in 2025, providing a comprehensive analysis by region and market sector of projected Drug Subcontractor sales for 2026 through 2032. With Drug Subcontractor sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Subcontractor industry.

This Insight Report provides a comprehensive analysis of the global Drug Subcontractor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Subcontractor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug Subcontractor market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Subcontractor and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Subcontractor.

This report presents a comprehensive overview, market shares, and growth opportunities of Drug Subcontractor market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Fully-automatic
  • Semi-automatic
Segmentation by Application:
  • Private Hospital
  • Public Hospital
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • JVM
  • Takazono Corporation
  • TOSHO
  • JHNT
  • SANYO
  • Cretem
  • Allon Technology
  • Yuyama Manufacturing
  • Beijing Huakangxin Medical
  • Suzhou Huisiteng
  • Shanghai Qiyou Precision Mechanical and Electrical
  • Jiangsu Fowa Medical
Key Questions Addressed in this Report

What is the 10-year outlook for the global Drug Subcontractor market?
What factors are driving Drug Subcontractor market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drug Subcontractor market opportunities vary by end market size?
How does Drug Subcontractor break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Drug Subcontractor Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Drug Subcontractor by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Drug Subcontractor by Country/Region, 2021, 2025 & 2032
2.2 Drug Subcontractor Segment by Type
  2.2.1 Fully-automatic
  2.2.2 Semi-automatic
  2.2.3 Drug Subcontractor Sales by Type
    2.2.3.1 Global Drug Subcontractor Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Drug Subcontractor Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Drug Subcontractor Sale Price by Type (2021-2026)
2.3 Drug Subcontractor Segment by Application
  2.3.1 Private Hospital
  2.3.2 Public Hospital
  2.3.3 Drug Subcontractor Sales by Application
    2.3.3.1 Global Drug Subcontractor Sale Market Share by Application (2021-2026)
    2.3.3.2 Global Drug Subcontractor Revenue and Market Share by Application (2021-2026)
    2.3.3.3 Global Drug Subcontractor Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Drug Subcontractor Breakdown Data by Company
  3.1.1 Global Drug Subcontractor Annual Sales by Company (2021-2026)
  3.1.2 Global Drug Subcontractor Sales Market Share by Company (2021-2026)
3.2 Global Drug Subcontractor Annual Revenue by Company (2021-2026)
  3.2.1 Global Drug Subcontractor Revenue by Company (2021-2026)
  3.2.2 Global Drug Subcontractor Revenue Market Share by Company (2021-2026)
3.3 Global Drug Subcontractor Sale Price by Company
3.4 Key Manufacturers Drug Subcontractor Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Drug Subcontractor Product Location Distribution
  3.4.2 Players Drug Subcontractor Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR DRUG SUBCONTRACTOR BY GEOGRAPHIC REGION

4.1 World Historic Drug Subcontractor Market Size by Geographic Region (2021-2026)
  4.1.1 Global Drug Subcontractor Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Drug Subcontractor Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Drug Subcontractor Market Size by Country/Region (2021-2026)
  4.2.1 Global Drug Subcontractor Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Drug Subcontractor Annual Revenue by Country/Region (2021-2026)
4.3 Americas Drug Subcontractor Sales Growth
4.4 APAC Drug Subcontractor Sales Growth
4.5 Europe Drug Subcontractor Sales Growth
4.6 Middle East & Africa Drug Subcontractor Sales Growth

5 AMERICAS

5.1 Americas Drug Subcontractor Sales by Country
  5.1.1 Americas Drug Subcontractor Sales by Country (2021-2026)
  5.1.2 Americas Drug Subcontractor Revenue by Country (2021-2026)
5.2 Americas Drug Subcontractor Sales by Type (2021-2026)
5.3 Americas Drug Subcontractor Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Drug Subcontractor Sales by Region
  6.1.1 APAC Drug Subcontractor Sales by Region (2021-2026)
  6.1.2 APAC Drug Subcontractor Revenue by Region (2021-2026)
6.2 APAC Drug Subcontractor Sales by Type (2021-2026)
6.3 APAC Drug Subcontractor Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Drug Subcontractor by Country
  7.1.1 Europe Drug Subcontractor Sales by Country (2021-2026)
  7.1.2 Europe Drug Subcontractor Revenue by Country (2021-2026)
7.2 Europe Drug Subcontractor Sales by Type (2021-2026)
7.3 Europe Drug Subcontractor Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Drug Subcontractor by Country
  8.1.1 Middle East & Africa Drug Subcontractor Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Drug Subcontractor Revenue by Country (2021-2026)
8.2 Middle East & Africa Drug Subcontractor Sales by Type (2021-2026)
8.3 Middle East & Africa Drug Subcontractor Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug Subcontractor
10.3 Manufacturing Process Analysis of Drug Subcontractor
10.4 Industry Chain Structure of Drug Subcontractor

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Drug Subcontractor Distributors
11.3 Drug Subcontractor Customer

12 WORLD FORECAST REVIEW FOR DRUG SUBCONTRACTOR BY GEOGRAPHIC REGION

12.1 Global Drug Subcontractor Market Size Forecast by Region
  12.1.1 Global Drug Subcontractor Forecast by Region (2027-2032)
  12.1.2 Global Drug Subcontractor Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Drug Subcontractor Forecast by Type (2027-2032)
12.7 Global Drug Subcontractor Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 JVM
  13.1.1 JVM Company Information
  13.1.2 JVM Drug Subcontractor Product Portfolios and Specifications
  13.1.3 JVM Drug Subcontractor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 JVM Main Business Overview
  13.1.5 JVM Latest Developments
13.2 Takazono Corporation
  13.2.1 Takazono Corporation Company Information
  13.2.2 Takazono Corporation Drug Subcontractor Product Portfolios and Specifications
  13.2.3 Takazono Corporation Drug Subcontractor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Takazono Corporation Main Business Overview
  13.2.5 Takazono Corporation Latest Developments
13.3 TOSHO
  13.3.1 TOSHO Company Information
  13.3.2 TOSHO Drug Subcontractor Product Portfolios and Specifications
  13.3.3 TOSHO Drug Subcontractor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 TOSHO Main Business Overview
  13.3.5 TOSHO Latest Developments
13.4 JHNT
  13.4.1 JHNT Company Information
  13.4.2 JHNT Drug Subcontractor Product Portfolios and Specifications
  13.4.3 JHNT Drug Subcontractor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 JHNT Main Business Overview
  13.4.5 JHNT Latest Developments
13.5 SANYO
  13.5.1 SANYO Company Information
  13.5.2 SANYO Drug Subcontractor Product Portfolios and Specifications
  13.5.3 SANYO Drug Subcontractor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 SANYO Main Business Overview
  13.5.5 SANYO Latest Developments
13.6 Cretem
  13.6.1 Cretem Company Information
  13.6.2 Cretem Drug Subcontractor Product Portfolios and Specifications
  13.6.3 Cretem Drug Subcontractor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Cretem Main Business Overview
  13.6.5 Cretem Latest Developments
13.7 Allon Technology
  13.7.1 Allon Technology Company Information
  13.7.2 Allon Technology Drug Subcontractor Product Portfolios and Specifications
  13.7.3 Allon Technology Drug Subcontractor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Allon Technology Main Business Overview
  13.7.5 Allon Technology Latest Developments
13.8 Yuyama Manufacturing
  13.8.1 Yuyama Manufacturing Company Information
  13.8.2 Yuyama Manufacturing Drug Subcontractor Product Portfolios and Specifications
  13.8.3 Yuyama Manufacturing Drug Subcontractor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Yuyama Manufacturing Main Business Overview
  13.8.5 Yuyama Manufacturing Latest Developments
13.9 Beijing Huakangxin Medical
  13.9.1 Beijing Huakangxin Medical Company Information
  13.9.2 Beijing Huakangxin Medical Drug Subcontractor Product Portfolios and Specifications
  13.9.3 Beijing Huakangxin Medical Drug Subcontractor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Beijing Huakangxin Medical Main Business Overview
  13.9.5 Beijing Huakangxin Medical Latest Developments
13.10 Suzhou Huisiteng
  13.10.1 Suzhou Huisiteng Company Information
  13.10.2 Suzhou Huisiteng Drug Subcontractor Product Portfolios and Specifications
  13.10.3 Suzhou Huisiteng Drug Subcontractor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Suzhou Huisiteng Main Business Overview
  13.10.5 Suzhou Huisiteng Latest Developments
13.11 Shanghai Qiyou Precision Mechanical and Electrical
  13.11.1 Shanghai Qiyou Precision Mechanical and Electrical Company Information
  13.11.2 Shanghai Qiyou Precision Mechanical and Electrical Drug Subcontractor Product Portfolios and Specifications
  13.11.3 Shanghai Qiyou Precision Mechanical and Electrical Drug Subcontractor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 Shanghai Qiyou Precision Mechanical and Electrical Main Business Overview
  13.11.5 Shanghai Qiyou Precision Mechanical and Electrical Latest Developments
13.12 Jiangsu Fowa Medical
  13.12.1 Jiangsu Fowa Medical Company Information
  13.12.2 Jiangsu Fowa Medical Drug Subcontractor Product Portfolios and Specifications
  13.12.3 Jiangsu Fowa Medical Drug Subcontractor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.12.4 Jiangsu Fowa Medical Main Business Overview
  13.12.5 Jiangsu Fowa Medical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. Drug Subcontractor Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Drug Subcontractor Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Fully-automatic
Table 4. Major Players of Semi-automatic
Table 5. Global Drug Subcontractor Sales by Type (2021-2026) & (Units)
Table 6. Global Drug Subcontractor Sales Market Share by Type (2021-2026)
Table 7. Global Drug Subcontractor Revenue by Type (2021-2026) & ($ million)
Table 8. Global Drug Subcontractor Revenue Market Share by Type (2021-2026)
Table 9. Global Drug Subcontractor Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Drug Subcontractor Sale by Application (2021-2026) & (Units)
Table 11. Global Drug Subcontractor Sale Market Share by Application (2021-2026)
Table 12. Global Drug Subcontractor Revenue by Application (2021-2026) & ($ million)
Table 13. Global Drug Subcontractor Revenue Market Share by Application (2021-2026)
Table 14. Global Drug Subcontractor Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Drug Subcontractor Sales by Company (2021-2026) & (Units)
Table 16. Global Drug Subcontractor Sales Market Share by Company (2021-2026)
Table 17. Global Drug Subcontractor Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Drug Subcontractor Revenue Market Share by Company (2021-2026)
Table 19. Global Drug Subcontractor Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Drug Subcontractor Producing Area Distribution and Sales Area
Table 21. Players Drug Subcontractor Products Offered
Table 22. Drug Subcontractor Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Drug Subcontractor Sales by Geographic Region (2021-2026) & (Units)
Table 26. Global Drug Subcontractor Sales Market Share Geographic Region (2021-2026)
Table 27. Global Drug Subcontractor Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Drug Subcontractor Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Drug Subcontractor Sales by Country/Region (2021-2026) & (Units)
Table 30. Global Drug Subcontractor Sales Market Share by Country/Region (2021-2026)
Table 31. Global Drug Subcontractor Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Drug Subcontractor Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Drug Subcontractor Sales by Country (2021-2026) & (Units)
Table 34. Americas Drug Subcontractor Sales Market Share by Country (2021-2026)
Table 35. Americas Drug Subcontractor Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Drug Subcontractor Sales by Type (2021-2026) & (Units)
Table 37. Americas Drug Subcontractor Sales by Application (2021-2026) & (Units)
Table 38. APAC Drug Subcontractor Sales by Region (2021-2026) & (Units)
Table 39. APAC Drug Subcontractor Sales Market Share by Region (2021-2026)
Table 40. APAC Drug Subcontractor Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Drug Subcontractor Sales by Type (2021-2026) & (Units)
Table 42. APAC Drug Subcontractor Sales by Application (2021-2026) & (Units)
Table 43. Europe Drug Subcontractor Sales by Country (2021-2026) & (Units)
Table 44. Europe Drug Subcontractor Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Drug Subcontractor Sales by Type (2021-2026) & (Units)
Table 46. Europe Drug Subcontractor Sales by Application (2021-2026) & (Units)
Table 47. Middle East & Africa Drug Subcontractor Sales by Country (2021-2026) & (Units)
Table 48. Middle East & Africa Drug Subcontractor Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Drug Subcontractor Sales by Type (2021-2026) & (Units)
Table 50. Middle East & Africa Drug Subcontractor Sales by Application (2021-2026) & (Units)
Table 51. Key Market Drivers & Growth Opportunities of Drug Subcontractor
Table 52. Key Market Challenges & Risks of Drug Subcontractor
Table 53. Key Industry Trends of Drug Subcontractor
Table 54. Drug Subcontractor Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Drug Subcontractor Distributors List
Table 57. Drug Subcontractor Customer List
Table 58. Global Drug Subcontractor Sales Forecast by Region (2027-2032) & (Units)
Table 59. Global Drug Subcontractor Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Drug Subcontractor Sales Forecast by Country (2027-2032) & (Units)
Table 61. Americas Drug Subcontractor Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Drug Subcontractor Sales Forecast by Region (2027-2032) & (Units)
Table 63. APAC Drug Subcontractor Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Drug Subcontractor Sales Forecast by Country (2027-2032) & (Units)
Table 65. Europe Drug Subcontractor Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Drug Subcontractor Sales Forecast by Country (2027-2032) & (Units)
Table 67. Middle East & Africa Drug Subcontractor Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Drug Subcontractor Sales Forecast by Type (2027-2032) & (Units)
Table 69. Global Drug Subcontractor Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Drug Subcontractor Sales Forecast by Application (2027-2032) & (Units)
Table 71. Global Drug Subcontractor Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. JVM Basic Information, Drug Subcontractor Manufacturing Base, Sales Area and Its Competitors
Table 73. JVM Drug Subcontractor Product Portfolios and Specifications
Table 74. JVM Drug Subcontractor Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. JVM Main Business
Table 76. JVM Latest Developments
Table 77. Takazono Corporation Basic Information, Drug Subcontractor Manufacturing Base, Sales Area and Its Competitors
Table 78. Takazono Corporation Drug Subcontractor Product Portfolios and Specifications
Table 79. Takazono Corporation Drug Subcontractor Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Takazono Corporation Main Business
Table 81. Takazono Corporation Latest Developments
Table 82. TOSHO Basic Information, Drug Subcontractor Manufacturing Base, Sales Area and Its Competitors
Table 83. TOSHO Drug Subcontractor Product Portfolios and Specifications
Table 84. TOSHO Drug Subcontractor Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. TOSHO Main Business
Table 86. TOSHO Latest Developments
Table 87. JHNT Basic Information, Drug Subcontractor Manufacturing Base, Sales Area and Its Competitors
Table 88. JHNT Drug Subcontractor Product Portfolios and Specifications
Table 89. JHNT Drug Subcontractor Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. JHNT Main Business
Table 91. JHNT Latest Developments
Table 92. SANYO Basic Information, Drug Subcontractor Manufacturing Base, Sales Area and Its Competitors
Table 93. SANYO Drug Subcontractor Product Portfolios and Specifications
Table 94. SANYO Drug Subcontractor Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. SANYO Main Business
Table 96. SANYO Latest Developments
Table 97. Cretem Basic Information, Drug Subcontractor Manufacturing Base, Sales Area and Its Competitors
Table 98. Cretem Drug Subcontractor Product Portfolios and Specifications
Table 99. Cretem Drug Subcontractor Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Cretem Main Business
Table 101. Cretem Latest Developments
Table 102. Allon Technology Basic Information, Drug Subcontractor Manufacturing Base, Sales Area and Its Competitors
Table 103. Allon Technology Drug Subcontractor Product Portfolios and Specifications
Table 104. Allon Technology Drug Subcontractor Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Allon Technology Main Business
Table 106. Allon Technology Latest Developments
Table 107. Yuyama Manufacturing Basic Information, Drug Subcontractor Manufacturing Base, Sales Area and Its Competitors
Table 108. Yuyama Manufacturing Drug Subcontractor Product Portfolios and Specifications
Table 109. Yuyama Manufacturing Drug Subcontractor Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Yuyama Manufacturing Main Business
Table 111. Yuyama Manufacturing Latest Developments
Table 112. Beijing Huakangxin Medical Basic Information, Drug Subcontractor Manufacturing Base, Sales Area and Its Competitors
Table 113. Beijing Huakangxin Medical Drug Subcontractor Product Portfolios and Specifications
Table 114. Beijing Huakangxin Medical Drug Subcontractor Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Beijing Huakangxin Medical Main Business
Table 116. Beijing Huakangxin Medical Latest Developments
Table 117. Suzhou Huisiteng Basic Information, Drug Subcontractor Manufacturing Base, Sales Area and Its Competitors
Table 118. Suzhou Huisiteng Drug Subcontractor Product Portfolios and Specifications
Table 119. Suzhou Huisiteng Drug Subcontractor Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Suzhou Huisiteng Main Business
Table 121. Suzhou Huisiteng Latest Developments
Table 122. Shanghai Qiyou Precision Mechanical and Electrical Basic Information, Drug Subcontractor Manufacturing Base, Sales Area and Its Competitors
Table 123. Shanghai Qiyou Precision Mechanical and Electrical Drug Subcontractor Product Portfolios and Specifications
Table 124. Shanghai Qiyou Precision Mechanical and Electrical Drug Subcontractor Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Shanghai Qiyou Precision Mechanical and Electrical Main Business
Table 126. Shanghai Qiyou Precision Mechanical and Electrical Latest Developments
Table 127. Jiangsu Fowa Medical Basic Information, Drug Subcontractor Manufacturing Base, Sales Area and Its Competitors
Table 128. Jiangsu Fowa Medical Drug Subcontractor Product Portfolios and Specifications
Table 129. Jiangsu Fowa Medical Drug Subcontractor Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Jiangsu Fowa Medical Main Business
Table 131. Jiangsu Fowa Medical Latest Developments

LIST OF FIGURES

Figure 1. Picture of Drug Subcontractor
Figure 2. Drug Subcontractor Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug Subcontractor Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Drug Subcontractor Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Drug Subcontractor Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Drug Subcontractor Sales Market Share by Country/Region (2025)
Figure 10. Drug Subcontractor Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Fully-automatic
Figure 12. Product Picture of Semi-automatic
Figure 13. Global Drug Subcontractor Sales Market Share by Type in 2026
Figure 14. Global Drug Subcontractor Revenue Market Share by Type (2021-2026)
Figure 15. Drug Subcontractor Consumed in Private Hospital
Figure 16. Global Drug Subcontractor Market: Private Hospital (2021-2026) & (Units)
Figure 17. Drug Subcontractor Consumed in Public Hospital
Figure 18. Global Drug Subcontractor Market: Public Hospital (2021-2026) & (Units)
Figure 19. Global Drug Subcontractor Sale Market Share by Application (2025)
Figure 20. Global Drug Subcontractor Revenue Market Share by Application in 2026
Figure 21. Drug Subcontractor Sales by Company in 2026 (Units)
Figure 22. Global Drug Subcontractor Sales Market Share by Company in 2026
Figure 23. Drug Subcontractor Revenue by Company in 2026 ($ millions)
Figure 24. Global Drug Subcontractor Revenue Market Share by Company in 2026
Figure 25. Global Drug Subcontractor Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Drug Subcontractor Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Drug Subcontractor Sales 2021-2026 (Units)
Figure 28. Americas Drug Subcontractor Revenue 2021-2026 ($ millions)
Figure 29. APAC Drug Subcontractor Sales 2021-2026 (Units)
Figure 30. APAC Drug Subcontractor Revenue 2021-2026 ($ millions)
Figure 31. Europe Drug Subcontractor Sales 2021-2026 (Units)
Figure 32. Europe Drug Subcontractor Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Drug Subcontractor Sales 2021-2026 (Units)
Figure 34. Middle East & Africa Drug Subcontractor Revenue 2021-2026 ($ millions)
Figure 35. Americas Drug Subcontractor Sales Market Share by Country in 2026
Figure 36. Americas Drug Subcontractor Revenue Market Share by Country (2021-2026)
Figure 37. Americas Drug Subcontractor Sales Market Share by Type (2021-2026)
Figure 38. Americas Drug Subcontractor Sales Market Share by Application (2021-2026)
Figure 39. United States Drug Subcontractor Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Drug Subcontractor Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Drug Subcontractor Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Drug Subcontractor Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Drug Subcontractor Sales Market Share by Region in 2026
Figure 44. APAC Drug Subcontractor Revenue Market Share by Region (2021-2026)
Figure 45. APAC Drug Subcontractor Sales Market Share by Type (2021-2026)
Figure 46. APAC Drug Subcontractor Sales Market Share by Application (2021-2026)
Figure 47. China Drug Subcontractor Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Drug Subcontractor Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Drug Subcontractor Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Drug Subcontractor Revenue Growth 2021-2026 ($ millions)
Figure 51. India Drug Subcontractor Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Drug Subcontractor Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Drug Subcontractor Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Drug Subcontractor Sales Market Share by Country in 2026
Figure 55. Europe Drug Subcontractor Revenue Market Share by Country (2021-2026)
Figure 56. Europe Drug Subcontractor Sales Market Share by Type (2021-2026)
Figure 57. Europe Drug Subcontractor Sales Market Share by Application (2021-2026)
Figure 58. Germany Drug Subcontractor Revenue Growth 2021-2026 ($ millions)
Figure 59. France Drug Subcontractor Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Drug Subcontractor Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Drug Subcontractor Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Drug Subcontractor Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Drug Subcontractor Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Drug Subcontractor Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Drug Subcontractor Sales Market Share by Application (2021-2026)
Figure 66. Egypt Drug Subcontractor Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Drug Subcontractor Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Drug Subcontractor Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Drug Subcontractor Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Drug Subcontractor Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Drug Subcontractor in 2026
Figure 72. Manufacturing Process Analysis of Drug Subcontractor
Figure 73. Industry Chain Structure of Drug Subcontractor
Figure 74. Channels of Distribution
Figure 75. Global Drug Subcontractor Sales Market Forecast by Region (2027-2032)
Figure 76. Global Drug Subcontractor Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Drug Subcontractor Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Drug Subcontractor Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Drug Subcontractor Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Drug Subcontractor Revenue Market Share Forecast by Application (2027-2032)


More Publications